Literature DB >> 21046288

Second relapse in childhood acute lymphoblastic leukemia: a call for action.

Ketan Prasad Kulkarni, Ram Kumar Marwaha.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21046288     DOI： 10.1007/s12098-010-0283-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  5 in total

1.  Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

Authors:  Gesche Tallen; Richard Ratei; Georg Mann; Gertjan Kaspers; Felix Niggli; Alexandr Karachunsky; Wolfram Ebell; Gabriele Escherich; Martin Schrappe; Thomas Klingebiel; Ruediger Fengler; Günter Henze; Arend von Stackelberg
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

2.  Pattern of relapse in childhood ALL: challenges and lessons from a uniform treatment protocol.

Authors:  Laxman Singh Arya; S P Kotikanyadanam; Manorama Bhargava; Renu Saxena; Sudha Sazawal; Sameer Bakhshi; Anshu Khattar; Ketan P Kulkarni; Melissa Adde; Trib S Vats; Ian Magrath
Journal:  J Pediatr Hematol Oncol       Date:  2010-07       Impact factor: 1.289

3.  Survival outcome in childhood ALL: experience from a tertiary care centre in North India.

Authors:  K P Kulkarni; R K Marwaha; A Trehan; D Bansal
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

4.  Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

Authors:  Richard H Ko; Lingyun Ji; Phillip Barnette; Bruce Bostrom; Raymond Hutchinson; Elizabeth Raetz; Nita L Seibel; Clare J Twist; Elena Eckroth; Richard Sposto; Paul S Gaynon; Mignon L Loh
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

5.  Pattern of relapsed disease in childhood all: experience from a single tertiary care center in North India.

Authors:  K P Kulkarni; R K Marwaha; A Trehan; D Bansal
Journal:  Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.